Medicago

News

Rabies virus is next target for vaccine developer Medicago

Vaccine maker Medicago (TSX:MDG) has developed a technology that can turn tobacco leaves into vaccines quickly and inexpensively, and the biotechnology company’s new North Carolina site stands ready for influenza vaccine production. But when Medicago unveiled its new Research Triangle Park facility last November amid great fanfare, CEO Andrew Sheldon said he couldn’t disclose Medicago’s […]

News

Vaccine developer Medicago raises $11M from Philip Morris investment

Biotechnology company Medicago (TSX:MDG), whose technology makes vaccines from tobacco leaves, now has an additional $11.1 million from an investor who knows a thing or two about the golden leaf: Philip Morris (NYSE:PM). Medicago shareholders approved the investment, the second tranche of a $22.5 million private placement with the tobacco giant. Philip Morris is acquiring […]

News

Medicago’s RTP vaccine facility opens to address pandemics

Biotechnology company Medicago (TSX:MDG) now has a facility that needs just 30 days to turn into new flu vaccine the plant that has been the cornerstone of North Carolina’s economy for hundreds of years. Medicago makes vaccine from the leaves of tobacco plants. The Quebec City, Canada company formally opened its new plant in Research […]

News

Medicago readies to demo flu vaccine capabilities in new RTP plant

Biotechnology company Medicago (TSX:MDG) could soon demonstrate whether its technology can rapidly develop and manufacture vaccines to respond to potential pandemic and bioterror threats.  Medicago, which is part of a national project to develop vaccine capabilities to respond to virus threats, has launched operations in its Research Triangle Park, North Carolina facility. The company expects […]